The estimated Net Worth of Paul Rothman is at least $422 Thousand dollars as of 6 June 2024. Paul Rothman owns over 717 units of Merck & Co Inc stock worth over $82,247 and over the last 10 years he sold MRK stock worth over $0. In addition, he makes $340,000 as Independent Director at Merck & Co Inc.
Paul has made over 1 trades of the Merck & Co Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he exercised 717 units of MRK stock worth $82,247 on 6 June 2024.
The largest trade he's ever made was exercising 717 units of Merck & Co Inc stock on 6 June 2024 worth over $82,247. On average, Paul trades about 51 units every 0 days since 2014. As of 6 June 2024 he still owns at least 717 units of Merck & Co Inc stock.
You can see the complete history of Paul Rothman stock trades at the bottom of the page.
Dr. Paul B. Rothman is Independent Director of the Company. Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry, including through his positions as the CEO of Johns Hopkins Medicine and the Dean of Medical Faculty and Vice President for Medicine, The Johns Hopkins University, and his past experience as Dean and Head of Internal Medicine at Carver College of Medicine at the University of Iowa. In addition, his vast operational and management experience of a large-scale medical organization provide him with a deep understanding of the complexities of the U.S. healthcare delivery system and policy environment. Johns Hopkins University?Dean of the Medical Faculty and Vice President for Medicine (2012-present) Johns Hopkins Medicine ?Chief Executive Officer (2012-present) Carver College of Medicine at the University of Iowa Dean (2008-2012) ?Head of Internal Medicine (2004-2008).
As the Independent Director of Merck & Co Inc, the total compensation of Paul Rothman at Merck & Co Inc is $340,000. There are 13 executives at Merck & Co Inc getting paid more, with Kenneth Frazier having the highest compensation of $27,648,500.
Paul Rothman is 62, he's been the Independent Director of Merck & Co Inc since 2015. There are 11 older and 15 younger executives at Merck & Co Inc. The oldest executive at Merck & Co Inc is Thomas Cech, 73, who is the Independent Director.
Paul's mailing address filed with the SEC is 531 SOUTH SPRING STREET, , BURLINGTON, NC, 27215.
Over the last 15 years, insiders at Merck & Co Inc have traded over $138,980,380 worth of Merck & Co Inc stock and bought 48,209 units worth $1,563,736 . The most active insiders traders include Wendell P Weeks, Kenneth C Frazier, and Douglas M Jr Baker. On average, Merck & Co Inc executives and independent directors trade stock every 15 days with the average trade being worth of $5,050,222. The most recent stock trade was executed by Chirfi Guindo on 5 August 2024, trading 36,901 units of MRK stock currently worth $4,250,995.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Merck & Co Inc executives and other stock owners filed with the SEC include: